PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA
May 1, 2020, 00:00
10.1016/j.jval.2020.04.307
https://www.valueinhealthjournal.com/article/S1098-3015(20)30495-2/fulltext
Title :
PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30495-2&doi=10.1016/j.jval.2020.04.307
First page :
Section Title :
Open access? :
No
Section Order :
10172